EE05245B1 - N-(1-hdroksmetl-2,3-dihdrokspropl)-1,4,7-triskarboksmetl-1,4,7,10-tetraasatsklododekaani liitiumikompleksid, nende valmistamine ja kasutamine - Google Patents

N-(1-hdroksmetl-2,3-dihdrokspropl)-1,4,7-triskarboksmetl-1,4,7,10-tetraasatsklododekaani liitiumikompleksid, nende valmistamine ja kasutamine

Info

Publication number
EE05245B1
EE05245B1 EEP200300282A EEP200300282A EE05245B1 EE 05245 B1 EE05245 B1 EE 05245B1 EE P200300282 A EEP200300282 A EE P200300282A EE P200300282 A EEP200300282 A EE P200300282A EE 05245 B1 EE05245 B1 EE 05245B1
Authority
EE
Estonia
Prior art keywords
tetraazat
clododecane
tricarboxymethyl
dihydroxypropyl
dimethyl
Prior art date
Application number
EEP200300282A
Other languages
English (en)
Estonian (et)
Inventor
Platzek Johannes
Blaszkiewicz Peter
Petrov Orlin
Hoffmann Holger
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200300282A publication Critical patent/EE200300282A/xx
Publication of EE05245B1 publication Critical patent/EE05245B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02—Lithium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200300282A 2000-12-15 2001-12-05 N-(1-hdroksmetl-2,3-dihdrokspropl)-1,4,7-triskarboksmetl-1,4,7,10-tetraasatsklododekaani liitiumikompleksid, nende valmistamine ja kasutamine EE05245B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10064467A DE10064467C2 (de) 2000-12-15 2000-12-15 Lithium-Komplexe von N-(1-Hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecan, deren Herstellung und Verwendung
PCT/EP2001/014283 WO2002048119A2 (de) 2000-12-15 2001-12-05 Lithium-komplexe von n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecan, deren herstellung und verwendung

Publications (2)

Publication Number Publication Date
EE200300282A EE200300282A (et) 2003-10-15
EE05245B1 true EE05245B1 (et) 2009-12-15

Family

ID=7668584

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300282A EE05245B1 (et) 2000-12-15 2001-12-05 N-(1-hdroksmetl-2,3-dihdrokspropl)-1,4,7-triskarboksmetl-1,4,7,10-tetraasatsklododekaani liitiumikompleksid, nende valmistamine ja kasutamine

Country Status (35)

Country Link
US (1) US6894151B2 (me)
EP (1) EP1343770B1 (me)
JP (1) JP4399163B2 (me)
KR (1) KR100869627B1 (me)
CN (1) CN1229357C (me)
AR (1) AR035609A1 (me)
AT (1) ATE430737T1 (me)
AU (2) AU3165902A (me)
BG (1) BG66117B1 (me)
BR (1) BR0116219A (me)
CA (1) CA2431976C (me)
CY (1) CY1109280T1 (me)
CZ (1) CZ304573B6 (me)
DE (2) DE10064467C2 (me)
DK (1) DK1343770T3 (me)
EC (1) ECSP034676A (me)
EE (1) EE05245B1 (me)
ES (1) ES2325982T3 (me)
HK (1) HK1064098A1 (me)
HR (1) HRP20030576B1 (me)
HU (1) HU229657B1 (me)
IL (1) IL156432A0 (me)
ME (1) ME00157B (me)
MX (1) MXPA03005240A (me)
NO (1) NO324864B1 (me)
NZ (1) NZ526478A (me)
PL (1) PL204181B1 (me)
PT (1) PT1343770E (me)
RS (1) RS51862B (me)
RU (1) RU2003120513A (me)
SK (1) SK287424B6 (me)
TW (1) TWI302531B (me)
UY (1) UY27056A1 (me)
WO (1) WO2002048119A2 (me)
ZA (1) ZA200305421B (me)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1635878B1 (en) * 2003-06-25 2010-12-29 Guerbet Peptide conjugate for magnetic resonance imaging of matrix metalloproteinases
FR2867473B1 (fr) 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
CN1993357B (zh) * 2004-07-02 2011-10-19 伯拉考成像股份公司 用于磁共振成像(mri)的含有具有多羟基化取代基的螯合部分的高弛豫造影剂
EP1999118B1 (en) 2006-03-14 2012-10-17 Mallinckrodt LLC Metal complexes of tetraazamacrocycle derivatives
US7777029B2 (en) * 2006-05-02 2010-08-17 San Diego State University (Sdsu) Foundation Bifunctional chelators for sequestering lanthanides
DE102009057274B4 (de) 2009-12-02 2011-09-01 Bayer Schering Pharma Aktiengesellschaft Gadobutrolherstellung mittels Trioxobicyclo-octan
WO2011054480A1 (de) * 2009-11-09 2011-05-12 Bayer Schering Pharma Aktiengesellschaft Gadobutrolherstellung mittels keramischer membran
DE102009053252B3 (de) * 2009-11-09 2011-09-01 Bayer Schering Pharma Aktiengesellschaft Gadobutrolherstellung mittels keramischer Membran
DE102010013833A1 (de) 2010-03-29 2011-09-29 Bayer Schering Pharma Aktiengesellschaft Herstellung von Gadobutrol mittels Dimethylformamiddimethylacetal
DE102010023105A1 (de) 2010-06-04 2011-12-08 Bayer Schering Pharma Aktiengesellschaft Gadobutrolherstellung im Eintopfverfahren mittels DMF-acetal und N-Methylimidazol
PE20141325A1 (es) 2011-04-21 2014-10-08 Bayer Ip Gmbh Preparacion de gadobutrol de alta pureza
CN106543094A (zh) * 2016-11-04 2017-03-29 嘉实（湖南）医药科技有限公司 高纯度钆布醇的制备方法
KR101971435B1 (ko) * 2017-08-29 2019-04-24 주식회사 엔지켐생명과학 가도부트롤 중간체 및 이를 이용한 가도부트롤의 제조 방법
KR102033964B1 (ko) * 2018-01-19 2019-10-18 주식회사 엔지켐생명과학 가도테리돌 중간체 및 이를 이용한 가도테리돌 제조방법
CN111039885B (zh) * 2019-12-06 2021-03-05 广州康瑞泰药业有限公司 一种制备高纯度考布曲钙的方法
KR20210112910A (ko) * 2020-03-06 2021-09-15 주식회사 엔지켐생명과학 가도부트롤 주사제 제조를 위한 부형제인 칼코부트롤의 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4009119A1 (de) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE19724186C2 (de) * 1997-06-02 2002-07-18 Schering Ag Verfahren zur Mono- und 1,7-Bis-N-ß-Hydroxyalkylierung von Cyclen und die entsprechenden N-ß-Hydroxyalkyl-1,4,7,10-tetraazacyclododecan-Li-Salz-Komplexe

Also Published As

Publication number Publication date
EP1343770B1 (de) 2009-05-06
HU229657B1 (en) 2014-03-28
BG107901A (bg) 2004-06-30
NO20032523L (no) 2003-06-04
HRP20030576B1 (en) 2011-09-30
NO324864B1 (no) 2007-12-17
MXPA03005240A (es) 2003-09-25
EE200300282A (et) 2003-10-15
ME00157B (me) 2010-10-10
HUP0302563A2 (hu) 2003-12-29
KR20030077555A (ko) 2003-10-01
NZ526478A (en) 2006-04-28
PT1343770E (pt) 2009-07-20
ATE430737T1 (de) 2009-05-15
ZA200305421B (en) 2004-08-27
CY1109280T1 (el) 2014-07-02
SK7292003A3 (en) 2003-11-04
RS51862B (sr) 2012-02-29
HUP0302563A3 (en) 2011-04-28
JP2004515545A (ja) 2004-05-27
DE10064467C2 (de) 2002-10-31
UY27056A1 (es) 2002-07-31
NO20032523D0 (no) 2003-06-04
ES2325982T3 (es) 2009-09-28
US20020128472A1 (en) 2002-09-12
YU48103A (sh) 2006-05-25
KR100869627B1 (ko) 2008-11-21
BR0116219A (pt) 2006-02-21
PL204181B1 (pl) 2009-12-31
PL366141A1 (en) 2005-01-24
AU3165902A (en) 2002-06-24
AR035609A1 (es) 2004-06-16
DE10064467A1 (de) 2002-07-11
WO2002048119A3 (de) 2002-11-07
MEP15708A (en) 2010-06-10
TWI302531B (en) 2008-11-01
CN1481371A (zh) 2004-03-10
CN1229357C (zh) 2005-11-30
BG66117B1 (bg) 2011-05-31
WO2002048119A2 (de) 2002-06-20
CZ20031641A3 (cs) 2003-09-17
EP1343770A2 (de) 2003-09-17
HK1064098A1 (en) 2005-01-21
CA2431976A1 (en) 2002-06-20
US6894151B2 (en) 2005-05-17
HRP20030576A2 (en) 2005-06-30
ECSP034676A (es) 2003-08-29
AU2002231659B2 (en) 2007-07-05
DE50114889D1 (de) 2009-06-18
DK1343770T3 (da) 2009-08-10
SK287424B6 (sk) 2010-09-07
IL156432A0 (en) 2004-01-04
CZ304573B6 (cs) 2014-07-16
RU2003120513A (ru) 2004-12-27
JP4399163B2 (ja) 2010-01-13
CA2431976C (en) 2010-04-13

Similar Documents

Publication Publication Date Title
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
EE200100185A (et) Asendatud fenüülderivaadid, nende valmistamine jakasutamine
NO20023616D0 (no) Ny anvendelse
EE05158B1 (et) 1,5-bensotiasepiinid ja nende kasutamine antilipideemiliste vahenditena
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
EE05169B1 (et) Asendatud oksasolidinoonid ja nende kasutamine
CY2013032I1 (el) Συζυγη της εξενδινης-4 και η φαρμακευτικη τους χρηση
NO20021116D0 (no) Ny sammensetning
FI991485A (fi) Uusi farmaseuttinen koostumus
NO20005503D0 (no) Ny anvendelse
NO20014490D0 (no) Medisinske blandinger
EE05245B1 (et) N-(1-hdroksmetl-2,3-dihdrokspropl)-1,4,7-triskarboksmetl-1,4,7,10-tetraasatsklododekaani liitiumikompleksid, nende valmistamine ja kasutamine
EE200000621A (et) Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine
NO20021115L (no) Ny sammensetning
ID24782A (id) Popok sekali pakai
ID25571A (id) Popok sekali pakai
FI20000818A0 (fi) Dermatologinen käyttö ja valmiste
NO20013337D0 (no) Ny behandling
NO20030868D0 (no) N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid
FI19992609A (fi) Uusi koostumus
EE200200267A (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiinid ja nende kasutamine ravimina
SE9901136D0 (sv) Ny användning
SE9903962D0 (sv) Ny användning
SE0002629D0 (sv) Novel compounds and their use
DK1127052T3 (da) Substituerede 2-phenylbenzimidazoler, fremstilling og anvendelse heraf

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

GB1A Change in the ownership or in the address of the owner